Dr. Nikunj Jain
Co-Founder and HOD - Nuclear Medicine ,MBBS, DRM, DNB, FEBNM, FANMB, Dip. CBNC
Gallbladder Cancer occurs when healthy
cells lining the gallbladder start developing in an uncontrolled way and change
into cancer cells. Adenocarcinoma is the type of cancer that can arise from
cells of an adenoma in the lining of an adenoma from the inside of the gal
bladder (gallbladder). Of these two types, most (by far) gallbladder cancers
are of the first type.
The disease may be discovered by chance
if someone has an imaging test or surgery because they were being treated for
an unrelated condition, such as gallstones. The stage of gallbladder cancer is
the degree or spread of the cancer. The results of an examination, imaging
tests, and, if needed, tests that measure the amount of disease are used by
doctors to understand how much disease is present and to determine treatment.
Symptoms of
Gallbladder Cancer
Gallbladder cancer doesn't exhibit any
symptoms during the very first stages. Symptoms may be similar to those of
gallstones and other gallbladder diseases. Possible symptoms include:
Abdominal pain: Persistent pain or discomfort in the upper-right part of the abdomen
may occur, particularly as the disease progresses.
Jaundice: Yellowing of the skin and eyes can develop if the tumour blocks the
bile ducts and prevents bile from draining normally.
Nausea and vomiting: Some patients may experience nausea, vomiting, or discomfort after
eating.
Loss of appetite and unexplained weight loss: Reduced appetite and unintentional
weight loss may occur with advancing disease.
Abdominal swelling: Some patients may develop abdominal swelling or a feeling of fullness.
Fever and general weakness: Fever, tiredness, or weakness may occur, although these symptoms are
not specific to gallbladder cancer.
Causes and Risk
Factors of Gallbladder Cancer
Gallbladder cancer's actual cause is
unknown in most cases. It arises from abnormalities of the cells' growth and
division in the genetic material. There are certain conditions and factors that
make one more likely to develop the disease.
Gallstones: Gallstones are associated with an increased risk of gallbladder cancer,
particularly when they cause long-term irritation or inflammation. However,
most people with gallstones do not develop cancer.
Chronic gallbladder inflammation: Long-standing inflammation of the gallbladder may
increase the risk of abnormal cellular changes.
Gallbladder polyps: Some gallbladder polyps have a higher risk of malignancy, depending on
their size and other characteristics. Most polyps are not cancerous.
Age and sex: Gallbladder cancer is more common in older adults and occurs more
frequently in women than in men.
Certain bile duct conditions: Some structural abnormalities involving the bile ducts may increase the
risk of gallbladder cancer.
Family history and genetic factors: A family history of gallbladder cancer or certain
inherited conditions may contribute to risk in some individuals.
People with one or more risk factors
are not guaranteed to develop gallbladder cancer. Likewise, the disease is also
found in persons without known risk factors.
Types of Gallbladder
Cancer
Gallbladders that have cancer may be
classified based on the type of cells in which the cancer originates. The type
of the disease is identified to help doctors understand the disease and develop
a course of treatment.
1. Adenocarcinoma
Adenocarcinoma is the most common type
of gallbladder cancer. It is formed from a type of glandular cells that line
the inside of the gallbladder. The growth/restructuring of the various forms
may differ in rates of increase.
2. Papillary
Adenocarcinoma
A less common type of papillary
adenocarcinoma grows in finger-like projections. The spots can be less prone to
invade surrounding tissues at an early stage than other kinds of tumours, but
there are variations.
3. Squamous Cell
Carcinoma
Squamous cell carcinoma is a rare type
that develops from squamous cells and tends to be aggressive in the
gallbladder. It may spread fast and can have a poorer prognosis.
4. Adenosquamous
Carcinoma
Adenosquamous carcinoma is a mixture of
two cell types, glandular and squamous, both of which can form a cancer.
Occasionally unusual and may be more aggressive than a typical adenocarcinoma.
Traditionally, the exact type of tumour will be identified based on the tissue
that is retrieved with a biopsy or surgery (when applicable).
How Is Gallbladder
Cancer Diagnosed?
To diagnose gallbladder cancer, doctors
review the patient's history, perform a physical examination, and order lab
tests and imaging scans. None of the tests is appropriate for all patients.
Ultrasound: An abdominal ultrasound is often one of the first investigations used
to examine the gallbladder. It can help identify gallstones, thickening of the
gallbladder wall, masses, and changes in nearby structures.
CT scan: A computed tomography (CT scan) with the use of a contrast dye can help
give detailed images of the gallbladder and the liver, and any other lymph
nodes in the abdomen.
Blood tests: These can be used to check liver function and help determine if there
is any blockage in the bile duct. In some individuals, the presence of tumour
markers like CA 19-9 and CEA may be checked, but it isn't possible to diagnose
gallbladder cancer using these markers alone.
Biopsy: When a sample is removed and studied with a microscope. Decision for
biopsy prior to treatment is dependent on the clinical circumstance and the
treatment that is planned.
Role of PET-CT in
Gallbladder Cancer Diagnosis
PET-CT is a combination of positron
emission tomography (PET) and computed tomography (CT). PET can give
information about metabolic activity in the tissues, whereas CT can give
information about the structure of the tissues. The combined images can help assess
how far the disease has spread among certain patient populations with suspected
cancer.
A radioactive substance, called
fluorodeoxyglucose (FDG), is the tracer commonly used in this scan. Some cancer
cells consume glucose more quickly than the rest of the body, causing the area
of the tumour to show up as a “hot spot” on the images. However,
hypermetabolism does not necessarily indicate malignancy, and may indicate
infection or inflammatory processes.
1. Assessing Possible
Cancer Spread
Doctors might use PET-CT to get more
information about where the gallbladder cancer may have spread if they need
more information about lymph nodes or other organs. It is used as a means to
interpret its findings in conjunction with other investigations such as CT, MRI,
and clinical information.
2. Supporting
Treatment Planning
In some instances, PET-CT may be able
to offer more information that aids in determining the amount of disease and
which treatment options are best for the patient. It may be especially helpful if
standard imaging is inconclusive about the need for distant imaging diagnosis.
3. Evaluating
Suspected Recurrence
If there is a concern that the
gallbladder cancer has come back or spread, it may be necessary to have a
PET-CT after treatment. This will depend on the symptoms of the patient as well
as any previous treatment history and any other investigations which may have
been obtained. Note that PET-CT is not routinely used in the initial diagnosis
of suspected gallbladder tumour. Initially, ultrasound, contrast CT (and MRI)
are important.
Some cancer types may not be detected
by PET-CT, and gallbladder cancer cannot be definitively diagnosed using PET-CT
alone. In some cases, it may be necessary to take out and examine the tissue.
Molecular Diagnostics and Therapy offers diagnostic imaging services. Patients
are advised to consult with their physician beforehand on whether the PET-CT
scan is applicable for them or not and whether they wish to have the scan prior
to making a reservation.
Treatment Options for
Gallbladder Cancer
Treatment will vary for different types
of cancer, depending on the stage, location, and health status of the patient.
Sometimes it also includes surgery, chemotherapy, or radiotherapy (in some
cases), targeted treatment, as well as Immunotherapy. Sometimes, surgery can be
performed, in addition to offering hope for a cure, if the cancer is found
early enough in disease progression so that all traces of it may be completely
removed. If the disease becomes more severe, it might require systemic
medications that can control the spread of disease and/or reduce symptoms or
improve quality of life. Treatment is based on individual clinical findings and
imaging and pathological findings. Early medical assessment will be carried out
and a diagnosis made, and the doctor will be guided on further tests.
Conclusion
Gallbladder cancer may be a serious
condition and might not be recognized in the early stages. Symptoms include:
abdominal pain, jaundice, nausea, loss of appetite, and weight loss, but could
be from other non-cancer sources. You can be diagnosed with gallbladder cancer
by an ultrasound, computed tomography (CT) scan, magnetic resonance imaging
(MRI) scan, and a biopsy of the tissue.
Sometimes the PET-CT scan can be useful in deciding on treatment and/or assessing the spread of disease, or suspected recurrence of the cancer. Discuss which tests are needed with your doctor. Molecular Diagnostics and Therapy offers the most advanced services and technologies to the patient, always in the best way and with comfort.
Book tests, view reports, and manage your health records on the go. Experience convenient healthcare with Molecular Diagnostics and Therapy.